SERB Pharmaceuticals agreed to acquire Y-mAbs Therapeutics in an all-cash deal worth about $412 million.

US stocks rallied on Monday and won back most of their sharp loss from last week, when worries about how President Donald Trump’s tariffs may be punishing the economy sent a shudder through Wall ...

Naturgy shares fell after the company sold a stake valued at 1.38 billion euros ($1.60 billion), offloading treasury shares in a bid to increase its free float and qualify for admission to ...

The crypto-investment and data-center company reported weaker-than-expected earnings and revenue in the second quarter.

The biggest deterrent to bull market returns has been the "watershed destruction of U.S. confidence," says Paulsen. Since 1960, when U.S. consumer confidence has risen monthly, the S&P 500 average ...